Feature | Judy Harvey
Pulse oximetry, which directly monitors the patient's oxygenation, came into its own as standard medical practice 20 ...
December 04, 2006
News
CV Therapeutics has announced it will file a new drug application to the FDA for its regadenoson agent in mid-2007 ...
December 04, 2006
Case Study
One of the major dilemmas faced by clinicians in the Intensive Care Unit (ICU) is the determination of volume status and ...
December 04, 2006Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
The Society for Cardiac Angiography and Interventions (SCAI) has extended the abstract deadline for its 30th Annual ...
December 04, 2006News
Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with ...
December 03, 2006News
Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators (ICDs), according to a study published in the December 2006 edition of “Heart Rhythm.”
December 03, 2006Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
AngioDynamics, Inc. has announced FDA 510(k) clearance for Oncobionic, Inc. to market Irreversible Electroporation (IRE) ...
December 03, 2006News
Possis Medical, Inc. has received clearance from the FDA to market its AngioJet Xpeedior catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. Used with the company’s AngioJet System, Xpeedior is the only device cleared for thrombectomy in peripheral veins.
December 03, 2006News
An innovative lead insulation material for cardiac leads used with pacemakers and ICDs is now FDA approved and available ...
November 29, 2006Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
The Third International Conference on Cell Therapy for Cardiovascular Diseases will convene Jan 17 to 19, at The New York Academy of Medicine in New York, NY. The three-day program is dedicated to the evolving field of cell-based therapies for cardiac repair and regeneration.
November 29, 2006News
GE Healthcare has launched its new LightSpeed VCT XT, the industry’s first CT scanner that maintains outstanding image ...
November 29, 2006News
An implantable technology to control high blood pressure in patients not responding to available medicines has ...
November 29, 2006Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
The FDA has cleared Toshiba's new EXCELART Vantage Atlas 1.5T MRI system, which the company showcased this week during ...
November 29, 2006News
November 2006 - Toshiba America Medical Systems, Inc. has announced a new partnership with CVCTA Education and San ...
November 20, 2006News
In its third quarter financial report, San Diego-based Cytori said it has moved significantly closer to initiating its cardiovascular clinical trials," said Christopher J. Calhoun, chief executive officer of Cytori Therapeutics. The company is developing adipose stem cells in cardiovascular disease and for use in reconstructive surgery.
November 20, 2006© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now